DexCom's SWOT analysis: cgm maker faces challenges amid stock volatility By...

Published on 16 Dec 2024 on Investing.com

DexCom (NASDAQ:DXCM), Inc., a leader in continuous glucose monitoring (CGM) systems for diabetes...

Read the rest of the article

Start tracking your investments with Statfolio

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:...

CNBC 20 Dec 2024

Omnicell's restructuring and cost-saving measures are also likely to drive major operational...

Zacks · via Yahoo Finance 20 Dec 2024

Abbott Laboratories’ ABT growth in the third quarter of 2024 can be attributed to strong sales re...

Zacks · via Yahoo Finance 19 Dec 2024

Whatever the answer is, it probably won't be dividend investing. Let's consider two income-focuse...

Motley Fool · via Yahoo Finance 19 Dec 2024

The latest development is expected to strengthen Abbott’s Cardiac Rhythm Management business, par...

Zacks · via Yahoo Finance 18 Dec 2024

It is hard to get excited after looking at Abbott Laboratories' (NYSE:ABT) recent performance, wh...

Simply Wall St. · via Yahoo Finance 17 Dec 2024

DexCom (NASDAQ:DXCM), Inc., a leader in continuous glucose monitoring (CGM) systems for diabetes...

Investing.com 16 Dec 2024

Abbott Laboratories (NYSE:ABT), a leading player in the medical technology sector with a market...

Investing.com 16 Dec 2024

The company has raised its dividend by an impressive average of 14% annually over the past decade...

Motley Fool · via Yahoo Finance 15 Dec 2024

Stocks in Gurus' Portfolio This Powerful Chart Made Peter Lynch 29% A Year For 13 Years How to...

GuruFocus.com · via Yahoo Finance 13 Dec 2024